ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2022 - 28th Pharmacovigilance 2022

Date2022-06-15 - 2022-06-16

Deadline2022-06-14

VenueEmbassy Suites by Hilton Boston at Logan Airport, USA - United States USA - United States

KeywordsPharma

Websitehttps://www.virtueinsight.com/event/phar...

Topics/Call fo Papers

28th Pharmacovigilance 2022
15th & 16th June 2022, Embassy Suites by Hilton Boston Logan Airport, Boston, USA
We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2022 edition, the agenda includes a host of new and exciting features. Take a chance and make it count by attending this conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.
SPONSORS: SYNOWLEDGE, August Research
DELEGATE REGISTRATION:
Email - kavitha-AT-virtueinsight.co.in or TEL: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
Standard Pricing - 1 Delegate-AT-£1,599+20% VAT
For Group Discount, Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha-AT-virtueinsight.co.in
KEY SPEAKERS:
• MICHAEL FRIES, Head, Biostatistics, CSL Behring
• JIM BUCHANAN, President, Covilance
• BRIAN DREYFUS, Senior Director -Solid Tumor Oncology Epidemiology, Bristol-Myers Squibb
• ELENA YURENEVA, Executive Director, Head of Medical Safety and Risk Management, Alnylam Pharmaceuticals
• AJINKYA INAMDAR, Director, Global Medical Safety, Global Safety Strategy and Risk Management, Janssen Pharmaceuticals
• NANCY DUBOIS, Head of Global Drug, Safety, United States Region, Merck-EMD Serono
• SHARON REID, Director, Risk Management Product Lead, Pfizer
• TEODORA DOHERTY, Global Medical Safety (GMS), Medical Safety Officer, Janssen Research & Development
• FATIMA GHETHAN, Head of Quality and Medication Safety Department, King Abdullah Medical City (KAMC) – MAKKAH (Saudi Arabia)
• HUMAIRA QURESHI, CEO, Synowledge
• MOHAMMED BASEER AHMED, Executive Director, Drug Safety, Ionis Pharmaceuticals
• TARAK THAKKER, Director, Safety Systems, BeiGene
• NIRJHAR CHATTERJEE, Medical Director Pharmacovigilance, Medical Safety Rare Genetics and Hematology & PDT, Takeda
• KATARINA ILIC, Senior Medical Director, Clinical Science, Rare, Genetics and Hematology TAU, Takeda Pharmaceuticals
• KAL ELHOREGY, Director, Risk Evaluation and Mitigation Strategy (REMS) Programs, Amneal Pharmaceuticals
• AYSE BAKER, Vice President of Regulatory Affairs, Almatica (Alvogen)
• SUTAPA MUKHOPADHYAY, Director, Pharmacovigilance Operations, Deciphera Pharmaceuticals
• MARCIN VON GROTTHUSS, Principal Scientist, Investigative Toxicology, Takeda Pharmaceuticals
• HEMANG MAISURIA, Director, Global Safety Lead, Servier Pharmaceuticals
• KAPIL BHUTADA, Director, Pharmacovigilance Compliance and Training, Medicago
• BILL HADDOCK, Head of Safety, Ovid Therapeutics
• NIBHA MISHRA, Senior Scientist, Investigative Toxicology, Takeda Pharmaceuticals
• JERRY K. KOUNGA, Investigational Drug Lead Clinical Research Pharmacist, Ascension Wisconsin Research Institute
• BEN LOCWIN, Executive SME, Black Diamond Networks
• JESSICA VAUGHN, Attorney at Law, Wiley Rein
• ELIZABETH WHITE BAKER, Associate Professor, Virginia Commonwealth University
• LYNN MEHLER, Partner, Hogan Lovells
WHO SHOULD ATTEND
CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:
Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical, Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Last modified: 2022-06-08 18:59:27